Want proof of ROI? Look at surviving cancer patients

UnknownPOST SUMMARY: Cancer Research UK analysis showed that in 1971-2, 50% of people diagnosed with cancer died within a year. Now 50% survive for at least a decade – up from 24% in 1971-2.  But the findings, based on the outcomes for more than 7 million patients, also showed that for some cancers, survival rates were still very low. For example, just 1% of pancreatic cancer patients and 5% of lung cancer patients can expect to survive for 10 years.  Nonetheless, the overall figures showed there had been significant progress in the way cancer was treated.  As we talk about mergers and acquisitions within the pharma industry we also need to ask how will these acquisitions effect the development of new drugs? Continue reading